Headline
The latest stories from AHA Today.
The Health Resources and Services Administration awarded $117 million in grants to expand HIV prevention and treatment services in high-risk areas as part of the administration’s plan to end the HIV epidemic.
Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’s Unapproved Drug Initiative, according to an analysis released by Vizient.
The Department of Health and Human Services is aware of 20 pharmaceutical products made or with a critical active ingredient solely sourced in China, but to date is not aware of any expected shortages, HHS Secretary Alex Azar told House appropriators.
he novel coronavirus (COVID-19) will spread in the U.S., and hospitals, communities and individuals should ramp up their preparedness efforts, Nancy Messonnier, M.D., director of the Centers for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases said.
The Food and Drug Administration approved the first generic albuterol sulfate inhaler to treat and prevent bronchospasms in patients with asthma or reversible obstructive airway disease.
Federal Trade Commissioner Christine Wilson clarified remarks published in certain publications last month that quoted her saying the agency will challenge every hospital merger in the pipeline.
Mallinckrodt Pharmaceuticals announced an agreement in principle on a settlement to resolve all opioid-related claims against the company in multidistrict litigation against drug makers and others over their alleged role in the opioid crisis.
The Food and Drug Administration released the first phase of its searchable Purple Book database, which includes all FDA-approved biosimilar and interchangeable products.
“The recent Modern Healthcare article ‘Top not-for-profit hospitals offer less charity care, study finds,’ does not tell the full story of how hospitals and health systems improve community health,” writes AHA President and CEO Rick Pollack in a letter to the editor.
The World Health Organization said that for the time being it will not categorize the novel coronavirus (COVID-19) outbreak a global pandemic, mainly because of the virus’ contained spread and lack of large-scale severe disease and deaths.